Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Nephrology
•
Nephrolithiasis
Do you recommend checking 1,25-hydroxy vitamin D levels in patients with recurrent nephrolithiasis who have hypercalciuria of unknown etiology?
Answer from: at Academic Institution
No, unless they are hypercalcemic or I suspect renal sarcoidosis. Stephen B Erickson, MD
Sign In
or
Register
to read more
Answer from: at Community Practice
It depends on the degree of the hypercalciuria and whether they also have hypercalcemia and what their PTH concentration is.
Sign In
or
Register
to read more
Answer from: at Community Practice
No, unless I’m concerned there may be a granulomatous process that is concerting (i.e. sarcoid, lymphoma) as a high 1,25 OH vitamins D in the context of persistent hypercalciuria and recurrent stones may inform my management decision.
Sign In
or
Register
to read more
24906
24932
25029
Related Questions
Do you recommend any specific testing for patients with recurrent nephrolithiasis and suspected absorptive hypercalciuria?
Do you rely on CT Hounsfield Units to determine stone composition in your patients with recurrent nephrolithiasis who have yet to submit a stone for laboratory based composition testing?
Do you routinely recommend decreasing dietary animal protein intake in patients with recurrent calcium oxalate nephrolithiasis who are found to have hyperoxaluria on 24 hour urine studies?
Which salt substitutes do you recommend for your patients with recurrent nephrolithiasis who have hypercalciuria from excess sodium chloride intake?
How do you advise your patients with recurrent nephrolithiasis to avoid consuming more than usual fluid volume on the day of a scheduled 24 hour urine stone risk study?
How do you recommend incorporating B-lines on lung POCUS as part of evaluating a patient's volume status?
How do you evaluate the etiology of hyponatremia in a patient with ESRD and baseline oliguria/anuria?
How would you approach management of retroperitoneal fibrosis causing ureteral compression that has already caused irreversible loss of kidney function?
Do you recommend vitamin C supplementation with PO iron in patients with iron deficiency?
Do you make any dose adjustments for patients with ESKD who are on apixaban and do not otherwise meet criteria for reduced dosing?